Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
As of: Sep 4, 2026 · 2:23 PM EDT

Compugen (CGEN) Operating Expenses (2009 - 2026)

Compugen (CGEN) posted quarterly Operating Expenses of $9.4 million for Q1 2026, up 13.17% year-over-year from $8.3 million in Q1 2025, and up 20.84% on a QoQ basis from $7.8 million in Q4 2025.

Analysis

Compugen (CGEN) Operating Expenses (2009 - 2026) Analysis & Trends

Compugen has reported Operating Expenses for 18 years, with the latest figure at $9.4 million in Q1 2026.

  • Operating Expenses for Q1 2026 came in at $9.4 million, up 13.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.3 million (down 2.57% YoY), and the FY2025 annual result was $32.2 million, down 7.58% from the prior year.
  • Operating Expenses improved to $9.4 million in Q1 2026, from $7.8 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $13.5 million in Q4 2023 and troughed at $7.8 million in Q4 2025.
  • A 5-year average of $9.6 million and a median of $9.4 million in 2026 frame the typical range for Operating Expenses.
  • The widest annual swing landed in 2023, when Operating Expenses surged 33.99%; it then sank 38.54% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $10.1 million in 2022, then soared by 33.99% to $13.5 million in 2023, then sank by 38.54% to $8.3 million in 2024, then declined by 6.35% to $7.8 million in 2025, then grew by 20.84% to $9.4 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $9.4 million in Q1 2026, $7.8 million in Q4 2025, and $8.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -1.05 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn - 505.13 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 541.02 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 427.03 Mn
10 Compugen 241.50 Mn 155.89 Mn -92,000.00 8.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.75 Mn
Mar 31, 2026 9.37 Mn
Dec 31, 2025 7.75 Mn
Sep 30, 2025 8.13 Mn
Jun 30, 2025 8.02 Mn
Mar 31, 2025 8.28 Mn
Dec 31, 2024 8.28 Mn
Sep 30, 2024 9.04 Mn
Jun 30, 2024 8.56 Mn
Mar 31, 2024 8.95 Mn
Dec 31, 2023 13.47 Mn
Sep 30, 2023 10.63 Mn
Jun 30, 2023 10.21 Mn
Mar 31, 2023 10.13 Mn
Dec 31, 2022 10.05 Mn
Sep 30, 2022 12.21 Mn
Jun 30, 2022 9.64 Mn
Mar 31, 2022 10.00 Mn
Dec 31, 2021 8.78 Mn
Sep 30, 2021 11.65 Mn